|
Volumn 18, Issue 3, 2004, Pages 421-
|
From viper's venom to drug design: Treating hypertension
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CHLOROTHIAZIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
PROPRANOLOL;
SULFANILAMIDE;
VERAPAMIL;
VIPER VENOM;
ANTIHYPERTENSIVE ACTIVITY;
BOTHROPS JARARACA;
DIABETES MELLITUS;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG STRUCTURE;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
IMPOTENCE;
KIDNEY;
NONHUMAN;
PRIORITY JOURNAL;
PROTECTION;
RENAL PROTECTION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SHORT SURVEY;
SIDE EFFECT;
SNAKE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
BOTHROPS;
CROTALID VENOMS;
DOGS;
DRUG DESIGN;
HISTORY, 18TH CENTURY;
HISTORY, 19TH CENTURY;
HISTORY, 20TH CENTURY;
HUMANS;
HYPERTENSION;
BOTHROPS;
BOTHROPS JARARACA;
SERPENTES;
|
EID: 1542343914
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fj.03-1398bkt Document Type: Short Survey |
Times cited : (32)
|
References (0)
|